Enefexine
![]() | |
| Clinical data | |
|---|---|
| Other names | 4-(4-Ethylphenyl)piperidine |
| Drug class | Antidepressant |
| Identifiers | |
IUPAC name
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H19N |
| Molar mass | 189.302 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
Enefexine (INN), also known as 4-(4-ethylphenyl)piperidine, is a drug of the phenylpiperidine group which is described as an antidepressant but was never marketed.[1][2] It was first described in the literature by 1983.[1][3] The drug was developed by Ciba-Geigy.[3]
See also
References
- 1 2 Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 519. ISBN 978-1-4757-2085-3. Retrieved 20 October 2024.
- ↑ Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (PDF). World Health Organization. 2024. p. 100. ISBN 978-92-4-009938-8.
- 1 2 CH 634298, Georges H, Alberto R, Giorgio FP, Oswald S, "Process for preparing phenylazacycloalkanes", published 31 January 1983, assigned to Ciba Geigy AG
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
